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The economic evaluation of health surveillance systems and of health information is a
methodological challenge, as for information systems in general. Main present threads
are considering cost-effectiveness solutions, minimizing costs for a given technically
required output, or cost-benefit analysis, balancing costs with economic benefits of duly
informed public interventions. The latter option, following a linear command-and-control
perspective, implies considering a main causal link between information, decision,
action, and health benefits. Yet, valuing information, taking into account its nature and
multiple sources, the modalities of its processing cycle, from production to diffusion,
decentralized use and gradual building of a shared information capital, constitutes
a promising challenge. This work proposes an interdisciplinary insight on the value
of health surveillance to get a renewed theoretical framework integrating information
and informatics theory and information economics. The reflection is based on a
typological approach of value, basically distinguishing between use and non-use values.
Through this structured discussion, the main idea is to expand the boundaries of
surveillance evaluation, to focus on changes and trends, on the dynamic and networked
structure of information systems, on the contribution of diverse data, and on the added
value of combining qualitative and quantitative information. Distancing itself from the
command-and-control model, this reflection considers the behavioral fundaments of
many health risks, as well as the decentralized, progressive and deliberative dimension of
decision-making in risk management. The framework also draws on lessons learnt from
recent applications within and outside of health sector, as in surveillance of antimicrobial
resistance, inter-laboratory networks, the use of big data or web sources, the diffusion
of technological products and large-scale financial risks. Finally, the paper poses the
bases to think the challenge of a workable approach to economic evaluation of health
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surveillance through a better understanding of health information value. It aims to
avoid over-simplifying the range of health information benefits across society while
keeping evaluation within the boundaries of what may be ascribed to the assessed
information system.
Keywords: complexity, decision-making, data, value, network, trend, typology, framework
INTRODUCTION
The economic evaluation of health surveillance systems remains
a methodological challenge, as it is for information systems in
general. This challenge is tied to that of defining what makes
the value of health information, be it generated inside or outside
of public surveillance systems. Main threads in this regard are
presently considering cost-effectiveness solutions, minimizing
costs for a given technically required output, cost-utility, then
depending on the way the latter concept is interpreted and
operationalized, or cost-benefit analysis, balancing costs with
economic benefits of duly informed public interventions. While
cost-effectiveness solutions are avoiding the question of benefits
and are subject to public choices to be made on other bases,
the present cost-benefit applications display some shortfalls
restricting their relevance in face of the diversity of health risks.
Indeed, following a linear command-and-control perspective
inspired from epidemic control procedures, those methods imply
considering a simplified link between information, decision,
action, and health benefits that is rather mono-causal and
short-term. By neglecting the complexity of health issues and
governance, these approaches may not take a faithful account
of a diversity of outcomes accruing from surveillance, and
might disfavor those oriented toward risks calling for long-term
processes for their control. Also, the realm of surveillance, rapidly
evolving in a highly connected world, fosters new challenges
about the evaluation of information, its quality and its overall
value. Hence, valuing information, taking into account its nature
and multiple sources, the modalities of its processing cycle,
from production to diffusion and decentralized use or effects,
as well as the gradual building of a shared information capital
and information commons, constitutes a promising challenge.
This work reflects on the value of health surveillance with an
interdisciplinary insight. Hopefully, these thoughts will add the
previous and current research and thoughts on surveillance
evaluation, especially its economics evaluation.
OVERVIEW OF APPROACHES IN
VALUATION OF SURVEILLANCE AND
HEALTH INFORMATION
The question of economic evaluation rests on the basic question
of what makes the value of the object under scrutiny. As
introduced, present approaches of economic evaluation of health
surveillance mostly tie the value of the system to the output
of the actions it has informed, i.e., to the epidemiological
evolution of the health risk to control. A refined framework
places this economic analysis within a stake of optimal allocation
of resources, based on the substitutability between surveillance
and mitigation costs (1, 2). Hence, the value of surveillance
more precisely lies in the avoided control costs. Mobilizing
a micro-economic reasoning based on the marginal analysis
of a mitigation function, this framework is most useful to
evaluate programs for which mitigation interventions are
directly informed by a surveillance system. However, concrete
applications of this optimization framework remain a challenge
as data on these trade-offs (substitutability) between surveillance
and mitigation are not yet available (3). The value of surveillance
is then evaluated jointly to that of intervention, through
the avoided losses, both in public and animal health (4, 5).
Since optimal allocation is out of reach in the present state
of knowledge, economic evaluation then aims at comparing
alternatives ex ante or evaluating ex post whether a realized
program delivered the expected value for money (6).
Different authors recognize the possibility for a surveillance
system to generate value even in absence of intervention, which
is then considered as intangible benefits, such as knowledge
(1, 7). These intangible benefits have been mostly left unevaluated
economically, due to methodological difficulties in including this
in the overall evaluation methodology. This neglect may also be
understood as a consequence of the minor role ascribed to those
intangibles compared to the concrete action-derived benefits,
which seems indeed justified in the above-mentioned epidemic
control systems.
Besides surveillance evaluation, the value of health
information has been explored within the so-called Value
of Information (VoI) framework (8). The VoI framework
considers the usefulness of information in improving the
decisions they underpin. This framework’s operationalization
will then basically depend on the extent to which one can observe
the quality of a decision, which is not obvious. Practically, the
improvement considered is one of uncertainty reduction and
the VoI framework will then be implemented through Bayesian
networks. Hence, the value of an additional information will
be tied to an overall change in the network of conditional
probabilities, with the quality of the decision being estimated
ex ante through the probabilistic summing of monetary
outcomes. This thinking thus pertains to marginal analysis,
considering the value of an additional unit of information to
assess whether it still exceeds its marginal cost. It is mostly
mobilized in the context of diagnostic procedures, considering
improvement along a gradient of certainty or accuracy of
a single measure or through the use of complementary
information (8).
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FUNDAMENTS TO RETHINK HEALTH
SURVEILLANCE VALUE
What Is Information? From Data
to Decision-Making
Information economics as developed 20 years ago by Shapiro
and Varian (9) consider information as “anything that is
or can be digitized” and that has value for consumers.
Recent frameworks for information system analysis propose
a fundamental distinction between data, information and
knowledge, or intelligence, then fuelling decision-making (10,
11). Data will be considered here as anything that can be
measured or characterized qualitatively and expressed in a
way that can be transmitted and processed. Data is thus the
raw material to produce information, which has the basic
property of being meaningful for a user. Once integrated
in a set of information and logically analyzed by human
thinking, this information contributes to the gradual building
of knowledge. Knowledge—i.e., human-processed information—
is what logically and ideally should drive decision-making in
complex settings. However, in more simple sub-systems or
through the experience of a system’s functioning, systematic
procedures may be decided and data or information may
be directly bonded to a particular action along established
processes (12). The latter systematization then corresponds
to the translation of information and then knowledge into
organization (13).
In health surveillance, in both public or animal health
contexts, the data considered are often the simple occurrence or
prevalence of a pathological condition, an infection or disease,
assessed through validated diagnostic protocols. In this context
working groups conducted by ECDC (European Center for
Disease Prevention and Control) have been established in order
to work on the data quality monitoring (14). In the even
more particular context of highly contagious infectious diseases
(possibly transboundary or exotic) and foodborne diseases, the
information system will be rather restricted to a function of
(early) warning system (such as the European Surveillance
System -TESSy- or PulseNet, the US national laboratory network
that connects foodborne illness cases to detect outbreaks), often
entailing pre-defined intervention procedures as detailed in
contingency plans (e.g., import bans, product recall,. . . ). Other
surveillance systems may be built in the prospect of confirming
freedom from a defined infection. However, this presentation of
surveillance as a provider of point-in-time information misses
the peculiarity of surveillance, which lies in its continuity and is
best exemplified in the case of endemic diseases surveillance (15).
Hence, surveillance data may be considered as generating
two types of information: punctual events and trends. From
the above, we may also propose to distinguish information
value along a second dichotomy of functions, i.e., its warning
or follow-up function. The decision that is pending on health
surveillance may also be subject to a tentative typology.
Obviously, the decisions may be directed toward the control of
the health issue under scrutiny, which we may term instrumental
decisions. From the two above-mentioned warning and follow-up
functions of surveillance information, we may further derive
two corresponding instrumental decision types, respectively,
a mitigation decision (setting a time-bound control action)
and a corrective decision (correcting the established control
system). Other decisions may rather act on the surveillance
system itself, here proposed as reflexive decisions, to be further
distinguished between structural and functional changes. Indeed,
while surveillance evaluation aims at such decisions, one should
not overlook the role of surveillance output itself in deciding
the increase or decrease of efforts in surveillance based on
his satisfaction regarding the observed trends (16). Again, this
points to the essential loop between information, decision and
organization (13). The here-proposed dichotomy of information
and ensuing decisions is summarized in Table 1 and Figure 1.
The Typology of Values Applied to Health
Information
Stemming from philosophy and economics, different typologies
of values are considered to better grasp the aims and methods
of a valuation (17). Each domain of valuation will mobilize and
further develop dichotomies in agreement with the nature of
its object. For a detailed description of concepts and in-depth
discussions, the reader may be redirected to works conducted
in the domains of environmental valuation (17) and domestic
biodiversity valuation (18).
First, a main case can be made here about the instrumental
nature of the value of health surveillance, serving the ultimately
valued objective of well-being, of human but also of animals,
which increasingly appears as a value for its own sake. The
latter precision pinpoints the fact that the opening of health
issues to multiple disciplines and stakeholders within the One
Health and EcoHealth approaches may require values at stake
to be reconsidered, in a pluralist ethical perspective, connecting
health to active debates in the two other domains cited here.
Beyond that central instrumentality of health information, the
present discussion may benefit from economic considerations
distinguishing between use and non-use values. Use value is the
value that agents ascribe to a good or service due to the use
they have of the latter, while non-use value is derived by agents
from the sole availability of the good or service, not involving any
direct or indirect use of it. Use values may further be divided into
active and passive use values, and non-use values into existence or
bequest values. How these categories apply to health information
will be later developed. An additional point to introduce among
TABLE 1 | Use values of health information considering decision type.
Punctual events Trends
Warning Short-term instrumental
decision:
• Mitigation
Long-term instrumental decision:
• Behavioral change
• Structural change
Follow-up Short-term instrumental
decision:
• Quality insurance
• Certification for freedom
status
Long-term reflexive decision:
• Structural change
• Functional change
Long-term instrumental decision:
• Corrective decision on control
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FIGURE 1 | Health information uses along decisional loops.
these fundaments is the economic notion of intrinsic value of an
object, which we define here as the value an agent ascribes to
an object per se [for detailed discussion of the various meanings
of the term intrinsic value please refer to (17)]. This will invite
us to clarify here the need to distinguish between the value of
information, the value of the surveillance system and the way the
two are related.
As considered in the VoI framework (8), the value of health
information and surveillance will be directly determined by the
context of uncertainty. This invites to a parallel with domestic
biodiversity, for which uncertainty is described to foster two
value types, i.e., the option and quasi-option values (18). The
option value is tied to the recognition of potential, unknown
future needs. It directly arises from risk aversion and holds
clear relevance to health information. The quasi-option value is
independent from risk aversion. It results from the irreversibility
of decisions in biodiversity management and thus the need
for information to improve that decision-making, motivating
to conserve biodiversity until enough is known about future
scenarios. Regarding health surveillance, this rhetoric of diversity
and portfolio management may be also used to consider the
array of data of interest that are collected about a set of health
issues. Hence, one might consider a value to that diversity of
surveillance objects as long as we lack the information needed
to choose between health issues to be prioritized. This pinpoints
the need to examine the value of a surveillance system within the
set of surveillance systems in place, as far as the stake is one of
allocation of limited resources between a diversity of risks. Also,
for one defined health issue, the array of data to be collected may
similarly display option and quasi-option values, since one may
not be certain which data will be of relevance in the face of the
evolution of the risk itself and our means to control it.
For the following, we will consider that the value of health
information may be instrumental in two ways. One is realized
through the control of health risks and corresponds to its
use value. The second responds directly to a behavioral need
for information and may be equated to the non-use value of
information, “use” being here restricted to the notion of decision-
making. We propose here to first set out the relevance of
considering non-use values and then to expose use values as a
major area of methodological challenges. The next developments
are summarized in Figure 2, which presents the proposed
dichotomy of values together with economic valuation methods.
Non-use Values
The direct value of information is driven by the aversion of actors
to risk and to ambiguity, who will then express an information-
seeking behavior, even in absence of pre-defined or resulting
decisional stake. This information-seeking behavior is a growing
field of research in health, mainly developed around doctors,
patients or specific social categories [e.g., (19–22)]. Additional
information may then provide a value to the user not by
improving a decision or action but by directly responding to an
ethological need for information. Let us note that the contrary
may also be observed, valuable information not being sought for,
or not enough, because of other psychological mechanisms, as
denial or avoidance (23). The latter consideration leads us to
consider the acceptability of information as an essential quality
trait, adding value to it.
Much of this direct value of information will pertain to its
form, i.e., the adequacy of the message expression with the
targeted beneficiaries, easing its diffusion and understanding
among actors as well as its acceptance. This conducts us to
include the demand for information in the society at large
within its valuation. This points to the crucial need for health
information to diffuse beyond the sole technical services directly
involved. Nevertheless, due to risks of panic, stigmatization, or
economic losses caused by the reaction to information, diffusion
may be questionable in some sensitive cases. These may even
lead to disservices of health surveillance. Therefore, the choice
of the content, formulation and medium for health messages
and particularly of the treatment that is made of uncertainty in
this communication will be of crucial importance in defining the
value of information.
An information may be first recognized to have a non-use
value for a defined actor but be retained till opportunities for
use show up. Therefore, part of this non-use value may be also
understood within the category of option value, also tied to risk
aversion, or that of quasi-option value, that is still applicable
to risk-neutral decision-makers. This would then indicate the
persistence of the availability of information as well as the
ease to organize it (repositories, interoperability) and memorize
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FIGURE 2 | Tree linking value types (bold) with information characteristics (white) and valuation methods (gray). The distinction into use and non-use values leads to
the inclusion of a diversity of tools of epidemiological or econometric nature. Each tool contributes to the modeling of a total value through the estimation of
value-specific parameters.
it, hence its simplicity, as a quality increasing this aspect of
information value.
Defining the non-use value of information according to its
meaningfulness to actors, the diversity of users entails a diversity
of forms information has to take, a diversity of information
and information services that has to be derived from a set of
data, as well as a diversity of data that has to be gathered.
Rather than starting from the epidemiological supply-side of
health data and information, recognizing the non-use value of
health information invites to jointly address the question from
the demand-side. This sheds light on the diffusion function
of surveillance system. Indeed, from the point of view of
the whole surveillance system, the realization of this direct
value entails the integration or close collaboration with health
communication services, whose performance assessment will
contribute to the valuation of surveillance. As for valuation
methods, the demand for information may be assessed through
well-established method of stated preferences, as provisionally
tested by Delabouglise et al. (24) with Vietnamese farmers in the
case of avian influenza. Such methods are widely used in raising
values for environmental services or biodiversity (17, 18) and
would benefit to surveillance evaluation by including a wider set
of actors and citizens, then raising the social demand-derived
value of health information.
Use Values
Separating Value From Actual Consequences
In agreement with the introductory statements, it is important
to consider the distinction between the use value of health
information and the value of the decision and action through
which it is mediated. This appears as the condition for a fair
evaluation of health surveillance, i.e., preventing the confusion
between a poor or delayed realization of actions and a poor
surveillance performance or usefulness. Therefore, the present
framework explicitly considers the use value as an intrinsic
value of information or surveillance, which will then have
to be handled and assessed on an ex ante basis. Hence the
expected consequences of duly mobilized health information
will be included in its evaluation, notwithstanding the reality
of its concretization, based on theoretical models linking its
characteristics to its usability. Such characteristics in fact mostly
correspond to the presently established qualities of surveillance
(6), which may then be distinguished between system-level
features and information-level features.
Accounting for the Trend
To deal first with information-level value, a crucial yet neglected
aspect of surveillance-produced information is its continuous
nature, hence expressed through trends as mentioned earlier.
Indeed, even when especially designed within the context of
monitoring systems and continuous real-time surveillance [e.g.,
(25, 26)], present evaluation frameworks tend to neglect the time
dimension of monitoring. Yet, the production of information
about trends is what centrally distinguishes surveillance from
any other point-in-time cross-sectional study. On another note,
the latter might in fact generate a wider diversity or increased
accuracy of information because it may be less limited for
its simplicity and acceptability, two important features of
surveillance systems. Therefore, the value derived from the
continuity, time-points density and timeframe of datasets has
to be acknowledged. These features of information intervene
in trade-offs with other qualities and values and are subject
to strategic and operational choices in active surveillance. In
particular, dense and complete follow-up datasets will be needed
to ascertain the absence of events, as opposed to an hypothesized
one. This may be critical if the link between two or more
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outbreaks detected at different timepoints has to be interpreted,
in absence or presence of data during the intervals.
Although the trend is a central value added of surveillance, its
intrinsic value lacks a framework, for which we may propose the
following basis. Let us consider a decision-maker facing follow-
up information within its corrective and reflexive assignments,
i.e., mobilizing health information in the continuous revision
of actions or of surveillance itself. As a starting point, a
surveillance system delivers to this decision-maker any of the
three conclusions about the trend over a given period of time:
increase, decrease or steady state. In face of this trend, the
decision-maker can be satisfied or not, as dissatisfaction is a
motivation for surveillance (16). Being satisfied, he/she will make
the decision of maintaining the interventions and surveillance
already in place. If one decision-maker is not satisfied with the
trend, he/she certainly will make the decision to induce changes
in the present risk management in order to modify the future
trend in the satisfying way. He/she may decide implementing the
interventions that were already planned or think over the most
effective and efficient interventions. Unfortunately, as for any
information, this trend may not correspond to the real evolution
of the risk under surveillance. Thus, the true trend can be an
increase, a decrease or a steady state, meaning that the conclusion
of the surveillance can be wrong in six cases out of nine (Table 2).
Whenever the decision to do something different or not is made
on a wrong conclusion of the surveillance system in comparison
to the actual trend, there is an economic cost. For example, not
detecting a true increase will postpone the decision to act, hence
paving the way for an increasing burden of the problem, whereas
failing to detect the decreasing trend consecutive to a set of
interventions will lead to the decision of maintaining, increasing
or changing the interventions in place when they are in fact less
or no longer relevant, hence unduly consuming resources.
The propensity of a system to produce conclusions about
trends corresponding to the real evolution should thus be
measured by the epidemiological sensitivity and specificity
applied to trends. At present, three definitions of surveillance
sensitivity exists: for case detection, for presence detection, and
for outbreak detection (27). We believe the latter can usefully be
expanded to deal with any trend in disease/agent occurrence as
schematized in Table 2. A recent study assessing the statistical
power of a surveillance system of endemic diseases in detecting
trend revealed the great challenges of surveillance sensitivity
related to trend (15). This should not impede our considerations
for this capacity to detect medium to long-term trends, which is
very specific to surveillance and crucial in raising awareness of
any disease increase or in confirming the impact of interventions.
Data Diversity Within the Digital and Societal
Evolutions of Surveillance
Health information within surveillance systems tends to be
considered under a restricted understanding of diagnostic
information regarding a well-defined condition and/or agent, as
it was also conceived here above. Surveillance is then considered
as an agent-specific tool. Yet, non-specific surveillance tends to
gain importance, through the development of technical platform-
based surveillance or syndromic surveillance in both public and
animal health and the use of indirect indicators of health (25, 28–
31). Structuring such surveillance systems, combining data of
diverse natures, is a technical challenge per se, as also experienced
e.g., in water quality surveillance (32), which will translate into
an increased complexity of its valuation as a whole and of
its components.
Also, less controlled information, which may provide
important signals and be crucial in determining the success
of health risk control, are not included in the evaluation
TABLE 2 | The decision-manager’s satisfaction (S) in face of trend detected through surveillance, the decision (D) to do something different, the relevance of the decision
(R) and the unnecessary economic cost incurred (UC) considering the true (unknown) trend.
True trend
Increase Steady state Decrease
Estimated
Trend
Increase S: no
D: yes
R: yes
UC: none
S: no
D: yes
R: no
UC: unnecessary actions
implemented
S: no
D: yes
R: no
UC: unnecessary actions
implemented
Steady
state
S: yes*
D: no
R: no
UC: increasing burden,
expanding undetected
S: yes*
D: no (or yes)
R: yes
UC: none
S: yes*
D: no (or yes)
R: yes (or no)
UC: none
Decrease S: yes**
D: no***
R: no
UC: increasing burden,
expanding undetected
S: yes**
D: no***
R: yes
UC: none
S: yes**
D: no***
R: no (or yes)
UC: unnecessary actions
maintained
S, satisfied with the detected trend yes or no; D, making decision to do something different (yes) or not (no) for controlling the issue and modifying the trend; R, relevance of the decision:
yes if it fits the requirement according to the true trend no otherwise; UC, nature of the unnecessary cost incurred due to the decision to do or not to do something different relatively
to the requirement by the true trend; *or no if interventions already in place; **especially if interventions in place; ***or yes to relax the interventions in place.
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since they do not fit into these well-specified performance
assessment methodology. In this context, textual information on
the web (e.g., news articles, official disease reports, newsletters,
information flows on social networks) are relevant for early
detection of emerging infectious disease outbreaks (33). For
instance, Barboza et al. (34) have shown that the web monitoring
systems can detect avian influenza epizootics 12.7 days before
the official notification to the World Organization for Animal
Health (OIE). Event-based biosurveillance systems have been
created for mining articles published on the web (35). HealthMap
(36) proposes an interactive map which uses word-processing
algorithms frommultiple sources like news feeds, expert accounts
(e.g., ProMED-mail) and multinational monitoring reports, etc.
To this we could add that direct exchanges between health
surveillance agents and stakeholders may convey such crucial
qualitative information about events, acts or motives, which may
be critical in the correct interpretation of diagnostic data, though
posing new methodological challenges for disambiguation and
treatment of possible fake information. This remark may then
further be extended to the management of rumors, which may
enter fully into the scope of health surveillance, both in its
functions of data collection and information diffusion.
In addition to the evolution in data sources and their
accessibility, societal changes also influences the realm of health
risk and the future of surveillance. Especially, global trade, mass
gatherings and travel contribute to introducing pathogens into
new populations, creating the potential to develop into epidemics
and to generate data that relate to those outbreaks, e.g., West
Nile virus introduction and spread in New York (37), post-
festival measles outbreak in Germany (38) and H1N1 spread
through airline transportation (39). Interestingly, in the above
cases, even though the collection of data followed new routes,
the interpretation was performed using the established public
health approaches, showing a valuable degree of integration of
unforeseen events inside the surveillance system.
Hence, the accrual of data relevant to surveillance also takes
place outside of established structures. This may be handled by
duly considering in a same framework the dichotomy between
structured and unstructured collection of data, an attribute
that might affect the quality, depth and timeliness of data
collection, thus its intrinsic value. Outside of the healthcare
realm, significant advances have beenmade in integrated systems,
especially those relating to financial services (e.g., market
behavior) (40) and primary production (e.g., agriculture) (41, 42)
where the value creation of development of such a framework
would be easier to document and quantify. In particular in the
case of Chinese financial services, the accrual of both structured
and unstructured data from multiple sources has had a beneficial
impact in the provision of micro-credit to Small and Medium
Enterprises (SMEs). Specifically in the latter case, low-income
families and micro-enterprises in China lacked access to financial
services not because they lacked creditworthiness but merely
because banks and financial institutions historically lacked
appropriate data, information and capabilities to access the
creditworthiness of and effectively provide financial services to
this financially disadvantaged group (43). Parallel developments
in health would certainly deserve attention, representing new
methodological challenges for valuation in which participatory
ratings and expert opinions may hold an interesting role.
This decentralized collection of data and information further
invites to adopt network thinking in the valuation. Hence, actors
collecting data or information from different sources within
networks should be identified and considered as sources for a
centralized information management system (44). As a mirror of
the willingness to pay for information, the willingness to accept
compensation for delivering informationmay be also appreciated
through stated preference methods (24). Where a diversity of
data has to be gathered among a diversity of actors, collaborative
systems may be imagined (45). The development of customizable
platforms hosting data from different sources to enable precision
medicine are a striking example. An economic evaluation should
then adapt to such systems to include network and collaborative
dynamics and take account of data or information of diverse
quality, trust levels, sources and natures.
A strict exclusion of data and information from unofficial
and uncontrolled sources may be done with an idea of reaching
a technical optimum of data quality. However, such exclusion
will be made at the expense of data diversity and will lower
the vigilance regarding unexpected or not officially monitored
events, referring to the option and quasi-option value of data
diversity. The timeliness in detection of signals (e.g., infectious
disease domain) is challenging due to the ever-growing amount
of publications on the web and the heterogeneity of available data
(i.e., social media, news, databases).
Informing a Decentralized Decision-Making
The frameworks presented in the introductory overview all
consider surveillance under its function of informing centralized
decision-making (policy-making, interventions), mainly in the
public sector (46). In reality, health information is of interest
to a wide range of users, both in the public and private sectors,
including large or small organizations or even individuals and
communities. Each use delivers a distinct contribution to the
value to be recognized to information. If this decentralized use
value may be considered in the context of decision-making, one
should not downplay the even-more diffused behavioral impact
of information. The latter thus constitutes a challenge to be
valued on its own if fair evaluation of surveillance is to be built.
Indeed, the range of benefits of surveillance includes awareness
raising and change in attitudes and practices. While all these may
be somehow considered as “actions” or “interventions”, these
terms fail at translating the decentralized and plural nature of
decision-making. Many efforts in economic and epidemiological
modeling currently aim at representing the consequences of
this decentralized decision-making [e.g., (47)]. Also the social
dynamics behind behavioral change entail that information
may be produced and diffused without any effect until the
so-called “tipping point” is reached (48). Hence, the absence
of consequences does not mean an absence of value of that
information, which would be better judged through an evaluation
of awareness in the population in relation to information access.
Recognizing the varying degree of decentralization of
decision-making in the management of many health risks, this
framework thus first calls practically for a typology of users
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and demands. Also unexpected users and uses have to be
monitored. Since information is aimed at building knowledge
and influencing practices, surveillance evaluation should assess
knowledge, attitude and practices, analyzed in relation with
the access to information. Stated preference methods and
other participatory tools should contribute significantly to
the evaluation of health policy from the point of view of
its users, among others through the calculation and analysis
of actors’ willingness to pay (24, 49, 50). Efforts to further
develop and insert those methods within evaluation frameworks
should be pursued, as those would both produce meaningful
values for information, and also distinguish points of potential
improvements among the determinants of this value.
Networks effect in information diffusion and the role of
particular actors within those networks would be accounted for
in order to maximize the efficiency of diffusion (51). Indeed,
some actors in networks show particular centrality and a high
potential for information diffusion, or even further decryption
and reformulation to reach a wider audience. Targeted diffusion
and pushed informationmust be considered to reach these actors.
Also, a special attention has to be devoted to the relationship to be
built between the surveillance system and mass media, especially
under crisis circumstances (52).
Finally, different users will operate at distinct scales, entailing
different amplitudes of expected consequences from their use
of information, hence distinct intrinsic values tied to their
obtention of information. Some actors will eventually act at the
international level, while most surveillance systems are designed
and evaluated at the national level and might therefore miss these
positive externalities in their valuation.
Hence methodological developments are needed to develop
a demand-side valuation of health information, in agreement
with the seminal works of Shapiro and Varian (9). Such methods
may build on social network analysis and the modeling of
decentralized decision-making, as well as health behavioral
models. The modeling of intrinsic value of information based on
detailed operations of a variety of agents with distinct amplitude
in expected consequences represents a tremendous task, inter
alia entailing challenges for the selection of relevant system
boundaries, hence the range of stakeholders to be included
(value chain actors, spatial territory inhabitants, social networks).
However, such modeling would allow for optimizing strategies
well beyond the sole checking of the value for money of
surveillance programs. Also, this modeling might be restricted
to key players only. For a wider set of smaller agents showing
a use value of health information, one might consider using
stated preference methods, as in the case of non-use value but
targeting agents in their active role with respect to the health risk
under consideration.
The outcomes considered above about a decentralized use
of health information mainly pertain to changes in practices,
the epidemiological effect of which (either positive or negative)
would have to be modeled. Besides these health behavior effects,
a variety of outcomes may ensue from the tactical or strategical
use of information by actors, in social and economic spheres.
Particularly relevant examples may be sought in the livestock
sector, where animal health information appears as a strategic
stake for economic players, would this be for a direct use,
disclosure or withholding of this information (24, 44, 53).
Directly referring to the structure of the sectors involved, the
level of organization and empowerment in the chain (vertical and
horizontal integration), these outcomes may then relate to equity
and sustainability criteria that would be taken into account in the
health surveillance valuation.
SOCIO-ECONOMIC FEATURES OF THE
VALUE OF HEALTH INFORMATION
Beside the direct consequences for the development of new
methods and tools for surveillance evaluation, the present
framework also provides some insights on the socio-economic
features of health information and surveillance, which may
contribute to further methodological developments.
Toward a Value Chain of Health Information
The processing of data into meaningful information, then
aggregated to and analyzed within a body of workable knowledge,
may be considered as a process adding value to a raw material
in order to satisfy users’ demand. Therefore, the application of
value chain analysis framework may deliver interesting insights
on surveillance. Value chain analysis is a common tool in
economics, increasingly applied within the context of health risk
management (53).
Just as any value chain analysis helps increasing the quality
of the final product, improving governance, i.e., agreements
between actors and the overall institutional framework in which
those operate, its application to data and information could help
evaluating socio-economic stakes along the involved network
to improve its functioning. Equity concerns in value chain
analysis, through the study of the distribution of the value-
added between actors, also finds an interesting parallel in
information networks. Hence, diverse contributors, supplying
data, analysis or knowledge, should be acknowledged and find
their remuneration in the system in order for it to be continuous
and sustainable. These equity concerns then fully fall within the
scope of an economic evaluation of surveillance.
Management Consequences of Loops
The behavioral dimension of information seeking and the role
of knowledge, thus of information, in driving this behavior
leads to interesting loop effects. Such loop effects in the
cross-determination between organization and information were
already pinpointed in early works of information economics,
referring to a complexity theory framework (13). According to
the present proposition, information that a given stakeholder
receives and integrates in his/her thinking will further influence
his/her understanding, awareness of the unknown and raise
new demands for information. Therefore, at first, stakeholders
might be uncomfortable in asserting their needs for information,
which will be formed, defined, and expressed in a progressive
way, through an interactive process with the design and
implementation of the information system (54). Hence, this
process will translate into an increase of the demand and social
value of information. This non-linear dynamic of information
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demandmay justify initial active information-giving stages where
the value of it cannot be directly derived from demand, rather
expecting this demand to be later developed (i.e., information
needs being supply induced). Later on, this non-linearity will
invalidate the application of the law of diminishing returns to
information production and diffusion. Therefore, an optimum
would not be expected which would indicate the point at which
informational efforts have to stop. Obviously, a particular actor
(individual or institutional) may reach a level of information
at which his capacity to manage this information get saturated
(cognitive load), unless supported by algorithms. However, this
saturation may lead to a decision to invest in the increase of
this management capacity and better instruments for decision-
making, rather than limiting surveillance effort. Hence, the
decision of what to monitor. The decision of what to monitor
and to what extent will remain a political decision, based on a
prioritization that far exceeds the sole monetary or number-of-
lives stakes, all the more in health where panic, public anxiety
and political pressure may be determining. Socio-economics in
this understanding will indicate how to do surveillance, not what
to monitor or to what extent.
This same non-linearity dynamic leads to consequences on
system’s costs and sustainability. Indeed, from the growing
awareness and demand for information may result a gradual
sophistication of required information and potentially ever-
growing expenses. However, progress of knowledge and
understanding of health risk allows for gradual systematization
of part of surveillance activities, freeing up resources for new
needs. Hence, information systems are building on human
and infrastructural capital but also on informational capital
(a notion that is gaining popularity in business management
but needs rigorous conceptualization). Also, actors’ growing
interest and participation may decrease the public cost of
surveillance, through the expected decrease of willingness
to accept compensation to contribute data or information.
Crowd sourcing and private stakeholders networks would
then be able to contribute to or generate efficient surveillance,
documented in biodiversity surveillance (55). Finally, from the
perspective of surveillance evaluation and information valuation,
the priority should be given to adding value to the produced
information from the perspective of contributing stakeholders,
hence stimulating participation and therefore private and public
contributions to the surveillance system in terms of time,
financial and human resources.
APPLICATIONS OF PARTICULAR
RELEVANCE
A Framework Tailored for Complex
Systems
The present reflections are all the more relevant for complex
health risks, contrasting with the simple command-and-control
approach that is still driving much of public decision-making
in human and animal health. Indeed, the links between
information, decision-making and action become harder to
identify unequivocally in more complex surveillance systems,
e.g., systems integrating a diversity of sources in non-agent-
specific surveillance or systems in which direct interventions
based on surveillance outcomes are not planned or operated by
the same jurisdiction. Hence, taking account of this complexity
in information management becomes all the more crucial
as we engage in still poorly understood health risks, where
much uncertainty and controversies are prevailing (56, 57).
The surveillance of antimicrobial resistance at the human-
animal interface is an example of surveillance system applied
to such a complex issue. Many other relevant examples may
be sought in endemic infectious diseases, behavioral health
risks or environmental health, all of which require complex
strategies for their control, involving a set of actors with distinct
and sometimes conflicting decision-making processes. These
socio-political barriers to the integration of risk assessment
and governance will cause this complexity to remain (3),
representing a lasting demand for surveillance evaluation taking
this complexity into account.
Antimicrobial Resistance: The Case of
Canada
As mentioned earlier, antimicrobial resistance appears itself
as a highly complex health risk involving various sectors,
disciplines and actions in order to be controlled (58, 59). The
surveillance of antimicrobial resistance, covering a wide range
of pathogens, host species, environments and behaviors, may
serve as a paradigmatic illustration of the present proposal.
Indeed, these characteristics create an obvious distance with the
mainstream economic evaluation of surveillance, as a system
where information triggers control interventions in a linear logic.
The Canadian Integrated Program for Antimicrobial Resistance
Surveillance (CIPARS) stands as an example of a surveillance
system whose impacts relies on its indirect influence on policies
and behavior changes on the long term.
The CIPARS is managed within a national public health
organization (Public Health Agency of Canada) and actively
collects yearly resistance data on three critical microorganisms
that are pathogens of humans (Salmonella, Campylobacter) or
sentinel bacteria (Escherichia coli) from three main animal
species (poultry, swine, bovine) at different points of the food
chain, including the farm, the abattoir and retail food stores (60).
Participation of farmers and of slaughterhouses to this
surveillance system is entirely voluntary, thus the quality of
information produced by the system relies on a strong network
of contributors whose contribution depends on the perceived
usefulness of the system, which is realized at the value chain
level. Feedback of information to this category of end users is
then crucial for the sustainability and existence of the system.
In addition, no direct public intervention is derived from
the information that is produced over time. CIPARS aims at
influencing decision-making indirectly, by raising awareness and
influencing decision-making in a wide range of stakeholders.
Indeed, CIPARS shares its information with more than 600 end
users from interdisciplinary fields covering animal and public
health, including livestock and poultry producers, veterinarians,
physicians and licensing bodies, local, provincial and federal
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public health and animal health organizations, pharmaceutical
organizations, drug and food regulators, animal and farm
advocacy groups, and researchers. Capturing the value of such
surveillance system crucially needs to widen the current barriers
of surveillance evaluation (61).
The Consolidated Microbiology Networks
The consolidatedmicrobiology networks (CMNs) are an example
of another complex health system. They are existing non-agent-
specific infrastructures that constitute an emerging structure
within healthcare systems, where the provision of diagnostic
services is centralized for multiple healthcare providers into
a single, new servicing unit (62). The emergence of CMNs
has been made possible through the technological advances in
the field of microbiology, allowing the simultaneous access to
information and processes, in real-time, and by many system
users; as well as the ability to multiplex technical components
providing a highly automated and standardized laboratory. It
is anticipated that in the future such CMNs would play an
increasing role in the routine health surveillance networks and
act as a major informational conduit, where well-defined and
structured data will be collected, interpreted and distributed for
downstream decision-making.
The creation and consolidation of CMNs is aided by the
fact that data from microbiology laboratories differ from most
other categories of patient data—blood pressure, body mass
index, etc. In the latter categories data can often become
interdependent requiring a higher informational load prior to
taking a decision. Microbiological analysis on the other hand
reports on specific, well-defined parameters on two independent
living organisms, patient and microbe. Data can thus often be
accessed and analyzed in useful ways independently of other
healthcare data (63). This independence and interest per se of
microbiological analyses does not preclude, however, the need to
analyze those in relation with patient data, especially to assess
the impact of infections (and crucially resistant pathogens) on
health and burden of disease. This again stresses the diversity of
stakes in surveillance data analysis, hence of the information to
be generated.
CMNs could become the first step toward a global set of sensor
networks for infectious diseases surveillance, where each one
of the world’s microbiology laboratories can be seen as a real-
time sensor and an increasingly discriminating reporter of the
microbes infecting patients in its area within an interconnected,
complex network (64). This makes good clinical and practical
sense. Most hospitals have infection preventionists, each of
whom works intensively to monitor the infectious diseases
trends, inform surveillance and control such spread within their
own hospital but often with little knowledge of what is trending in
the next hospital, or another part of the country. Comprehensive,
globally interpreted data shared between different end users and
health agencies is not technically impossible and might help
to close this gap. In such a scenario though the pressure to
establish a value framework beyond the existing approaches is
likely to intensify.
CONCLUSION
Quite obviously, the present thoughts do not pretend making of
a complex matter a simple question or providing simple answers.
Nor does it dismiss the usefulness of the present evaluation
frameworks, which have been guided by a highly practical sense
and the need to come up with values and fuel the public decision-
making. However, facing complex health risks, as underlined
by the One Health or EcoHealth frameworks, with highly
decentralized drivers, information valuation and surveillance
evaluation should gain insights from a broader account of
socio-economic and information sciences. Due to technological
advances, information represents a central challenge in today’s
world and will certainly continue to do so in the future. The
tremendous change in data collection, volume, processing and
diffusion abilities, and in the interface between individuals and
information, calls health surveillance economic evaluation to
get addressed within interdisciplinary teams, well beyond health
professionals or economists.
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